{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:25:27Z","timestamp":1790504727865,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Royal Golden Jubilee Ph.D. Scholarship Program","award":["(Grant No. PHD\/0060\/2561)"],"award-info":[{"award-number":["(Grant No. PHD\/0060\/2561)"]}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["N41A640162"],"award-info":[{"award-number":["N41A640162"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Mahidol University Basic Research Fund","award":["FF2022"],"award-info":[{"award-number":["FF2022"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73581-8","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T08:03:44Z","timestamp":1727683424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A live single-cell reporter system reveals drug-induced plasticity of a cancer stem cell-like population in cholangiocarcinoma"],"prefix":"10.1038","volume":"14","author":[{"given":"Krittiyabhorn","family":"Kongtanawanich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunisa","family":"Prasopporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supawan","family":"Jamnongsong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nontaphat","family":"Thongsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongchai","family":"Payungwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Methichit","family":"Wattanapanitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwanon","family":"Jirawatnotai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"73581_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/14737140.2023.2176846","volume":"23","author":"ZJ Brown","year":"2023","unstructured":"Brown, Z. J., Ruff, S. M. & Pawlik, T. M. Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy. Expert Rev. Anticancer Ther.23, 257\u2013264. https:\/\/doi.org\/10.1080\/14737140.2023.2176846 (2023).","journal-title":"Expert Rev. Anticancer Ther."},{"key":"73581_CR2","doi-asserted-by":"publisher","first-page":"850732","DOI":"10.3389\/fonc.2022.850732","volume":"12","author":"Q Zheng","year":"2022","unstructured":"Zheng, Q., Zhang, B., Li, C. & Zhang, X. Overcome Drug Resistance in Cholangiocarcinoma: New Insight into mechanisms and Refining the preclinical experiment models. Front. Oncol.12, 850732. https:\/\/doi.org\/10.3389\/fonc.2022.850732 (2022).","journal-title":"Front. Oncol."},{"key":"73581_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med.23, 1124\u20131134. https:\/\/doi.org\/10.1038\/nm.4409 (2017).","journal-title":"Nat. Med."},{"key":"73581_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41568-020-0263-0","volume":"20","author":"TG Phan","year":"2020","unstructured":"Phan, T. G. & Croucher, P. I. The dormant cancer cell life cycle. Nat. Rev. Cancer. 20, 398\u2013411. https:\/\/doi.org\/10.1038\/s41568-020-0263-0 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"73581_CR5","doi-asserted-by":"publisher","unstructured":"Phi, L. T. H. et al. Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment. Stem Cells Int. 5416923. (2018). https:\/\/doi.org\/10.1155\/2018\/5416923 (2018).","DOI":"10.1155\/2018\/5416923"},{"key":"73581_CR6","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc1590","volume":"5","author":"M Dean","year":"2005","unstructured":"Dean, M., Fojo, T. & Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer. 5, 275\u2013284. https:\/\/doi.org\/10.1038\/nrc1590 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"73581_CR7","doi-asserted-by":"publisher","unstructured":"Kamimoto, K. et al. Heterogeneity and stochastic growth regulation of biliary epithelial cells dictate dynamic epithelial tissue remodeling. Elife. 5. https:\/\/doi.org\/10.7554\/eLife.15034 (2016).","DOI":"10.7554\/eLife.15034"},{"key":"73581_CR8","doi-asserted-by":"publisher","first-page":"824261","DOI":"10.3389\/fphys.2021.824261","volume":"12","author":"K Tamai","year":"2021","unstructured":"Tamai, K., Fujimori, H., Mochizuki, M. & Satoh, K. Cancer Stem cells in Intrahepatic Cholangiocarcinoma; their molecular basis, and therapeutic implications. Front. Physiol.12, 824261. https:\/\/doi.org\/10.3389\/fphys.2021.824261 (2021).","journal-title":"Front. Physiol."},{"key":"73581_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3892\/ijo.2020.5074","volume":"57","author":"NA McGrath","year":"2020","unstructured":"McGrath, N. A., Fu, J., Gu, S. Z. & Xie, C. Targeting cancer stem cells in cholangiocarcinoma (review). Int. J. Oncol.57, 397\u2013408. https:\/\/doi.org\/10.3892\/ijo.2020.5074 (2020).","journal-title":"Int. J. Oncol."},{"key":"73581_CR10","doi-asserted-by":"publisher","unstructured":"Wu, H. J. & Chu, P. Y. Role of Cancer Stem cells in Cholangiocarcinoma and therapeutic implications. Int. J. Mol. Sci.20. https:\/\/doi.org\/10.3390\/ijms20174154 (2019).","DOI":"10.3390\/ijms20174154"},{"key":"73581_CR11","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.ajpath.2015.02.010","volume":"185","author":"V Cardinale","year":"2015","unstructured":"Cardinale, V. et al. Profiles of cancer stem cell subpopulations in cholangiocarcinomas. Am. J. Pathol.185, 1724\u20131739. https:\/\/doi.org\/10.1016\/j.ajpath.2015.02.010 (2015).","journal-title":"Am. J. Pathol."},{"key":"73581_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/ijc.25317","volume":"128","author":"M Wang","year":"2011","unstructured":"Wang, M. et al. Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties. Int. J. Cancer. 128, 72\u201381. https:\/\/doi.org\/10.1002\/ijc.25317 (2011).","journal-title":"Int. J. Cancer"},{"key":"73581_CR13","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.21873\/anticanres.12516","volume":"38","author":"M Kawamoto","year":"2018","unstructured":"Kawamoto, M. et al. Combined Gemcitabine and Metronidazole is a Promising Therapeutic Strategy for Cancer stem-like Cholangiocarcinoma. Anticancer Res.38, 2739\u20132748. https:\/\/doi.org\/10.21873\/anticanres.12516 (2018).","journal-title":"Anticancer Res."},{"key":"73581_CR14","doi-asserted-by":"publisher","first-page":"17667","DOI":"10.1038\/s41598-017-17804-1","volume":"7","author":"C Raggi","year":"2017","unstructured":"Raggi, C. et al. Dysregulation of Iron Metabolism in Cholangiocarcinoma stem-like cells. Sci. Rep.7, 17667. https:\/\/doi.org\/10.1038\/s41598-017-17804-1 (2017).","journal-title":"Sci. Rep."},{"key":"73581_CR15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/cr.2012.13","volume":"22","author":"DG Tang","year":"2012","unstructured":"Tang, D. G. Understanding cancer stem cell heterogeneity and plasticity. Cell. Res.22, 457\u2013472. https:\/\/doi.org\/10.1038\/cr.2012.13 (2012).","journal-title":"Cell. Res."},{"key":"73581_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature25167","volume":"553","author":"M Milanovic","year":"2018","unstructured":"Milanovic, M. et al. Senescence-associated reprogramming promotes cancer stemness. Nature. 553, 96\u2013100. https:\/\/doi.org\/10.1038\/nature25167 (2018).","journal-title":"Nature"},{"key":"73581_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","volume":"18","author":"NK Lytle","year":"2018","unstructured":"Lytle, N. K., Barber, A. G. & Reya, T. Stem cell fate in cancer growth, progression and therapy resistance. Nat. Rev. Cancer. 18, 669\u2013680. https:\/\/doi.org\/10.1038\/s41568-018-0056-x (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"73581_CR18","doi-asserted-by":"publisher","unstructured":"Poleszczuk, J. & Enderling, H. Cancer Stem Cell Plasticity as Tumor Growth Promoter and Catalyst of Population Collapse. Stem Cells Int. 3923527. (2016). https:\/\/doi.org\/10.1155\/2016\/3923527 (2016).","DOI":"10.1155\/2016\/3923527"},{"key":"73581_CR19","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/j.tranon.2020.100909","volume":"14","author":"V Richard","year":"2021","unstructured":"Richard, V., Kumar, T. R. S. & Pillai, R. M. Transitional dynamics of cancer stem cells in invasion and metastasis. Transl Oncol.14, 100909. https:\/\/doi.org\/10.1016\/j.tranon.2020.100909 (2021).","journal-title":"Transl Oncol."},{"key":"73581_CR20","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A Perez-Gonzalez","year":"2023","unstructured":"Perez-Gonzalez, A., Bevant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer. 4, 1063\u20131082. https:\/\/doi.org\/10.1038\/s43018-023-00595-y (2023).","journal-title":"Nat. Cancer"},{"key":"73581_CR21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/MCB.25.6.2475-2485.2005","volume":"25","author":"T Kuroda","year":"2005","unstructured":"Kuroda, T. et al. Octamer and Sox elements are required for transcriptional cis regulation of nanog gene expression. Mol. Cell. Biol.25, 2475\u20132485. https:\/\/doi.org\/10.1128\/MCB.25.6.2475-2485.2005 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"73581_CR22","doi-asserted-by":"publisher","first-page":"24731","DOI":"10.1074\/jbc.M502573200","volume":"280","author":"DJ Rodda","year":"2005","unstructured":"Rodda, D. J. et al. Transcriptional regulation of nanog by OCT4 and SOX2. J. Biol. Chem.280, 24731\u201324737. https:\/\/doi.org\/10.1074\/jbc.M502573200 (2005).","journal-title":"J. Biol. Chem."},{"key":"73581_CR23","doi-asserted-by":"publisher","first-page":"12822","DOI":"10.1074\/jbc.M611814200","volume":"282","author":"ZX Wang","year":"2007","unstructured":"Wang, Z. X. et al. Oct4 and Sox2 directly regulate expression of another pluripotency transcription factor, Zfp206, in embryonic stem cells. J. Biol. Chem.282, 12822\u201312830. https:\/\/doi.org\/10.1074\/jbc.M611814200 (2007).","journal-title":"J. Biol. Chem."},{"key":"73581_CR24","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4103\/jomfp.JOMFP_22_20","volume":"24","author":"N Swain","year":"2020","unstructured":"Swain, N., Thakur, M., Pathak, J. & Swain, B. SOX2, OCT4 and NANOG: the core embryonic stem cell pluripotency regulators in oral carcinogenesis. J. Oral Maxillofac. Pathol.24, 368\u2013373. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_22_20 (2020).","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"73581_CR25","doi-asserted-by":"publisher","unstructured":"Vaddi, P. K., Stamnes, M. A., Cao, H. & Chen, S. Elimination of SOX2\/OCT4-Associated prostate Cancer stem cells blocks Tumor Development and enhances therapeutic response. Cancers (Basel). 11. https:\/\/doi.org\/10.3390\/cancers11091331 (2019).","DOI":"10.3390\/cancers11091331"},{"key":"73581_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3349\/ymj.2018.59.1.35","volume":"59","author":"L You","year":"2018","unstructured":"You, L., Guo, X. & Huang, Y. Correlation of Cancer stem-cell markers OCT4, SOX2, and NANOG with Clinicopathological features and prognosis in operative patients with rectal Cancer. Yonsei Med. J.59, 35\u201342. https:\/\/doi.org\/10.3349\/ymj.2018.59.1.35 (2018).","journal-title":"Yonsei Med. J."},{"key":"73581_CR27","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/cimb43020041","volume":"43","author":"J Li","year":"2021","unstructured":"Li, J. et al. Identification and characterization of Cancer Stem-Like cells in ALK-Positive anaplastic large cell lymphoma using the SORE6 reporter. Curr. Issues Mol. Biol.43, 543\u2013557. https:\/\/doi.org\/10.3390\/cimb43020041 (2021).","journal-title":"Curr. Issues Mol. Biol."},{"key":"73581_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2021.09.044","volume":"162","author":"X Liang","year":"2022","unstructured":"Liang, X. et al. An enhancer-driven Stem Cell-Like Program mediated by SOX9 blocks intestinal differentiation in Colorectal Cancer. Gastroenterology. 162, 209\u2013222. https:\/\/doi.org\/10.1053\/j.gastro.2021.09.044 (2022).","journal-title":"Gastroenterology"},{"key":"73581_CR29","doi-asserted-by":"publisher","first-page":"188517","DOI":"10.1016\/j.bbcan.2021.188517","volume":"1875","author":"M Panda","year":"2021","unstructured":"Panda, M., Tripathi, S. K. & Biswal, B. K. SOX9: an emerging driving factor from cancer progression to drug resistance. Biochim. Biophys. Acta Rev. Cancer. 1875, 188517. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188517 (2021).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"73581_CR30","doi-asserted-by":"publisher","first-page":"100996","DOI":"10.1016\/j.gendis.2023.03.035","volume":"11","author":"T Shang","year":"2024","unstructured":"Shang, T. et al. Diverse functions of SOX9 in liver development and homeostasis and hepatobiliary diseases. Genes Dis.11, 100996. https:\/\/doi.org\/10.1016\/j.gendis.2023.03.035 (2024).","journal-title":"Genes Dis."},{"key":"73581_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.stemcr.2014.11.002","volume":"4","author":"B Tang","year":"2015","unstructured":"Tang, B. et al. A flexible reporter system for direct observation and isolation of cancer stem cells. Stem Cell. Rep.4, 155\u2013169. https:\/\/doi.org\/10.1016\/j.stemcr.2014.11.002 (2015).","journal-title":"Stem Cell. Rep."},{"key":"73581_CR32","doi-asserted-by":"publisher","unstructured":"Padua, D. et al. A SOX2 reporter system identifies gastric Cancer Stem-Like cells sensitive to Monensin. Cancers (Basel). 12. https:\/\/doi.org\/10.3390\/cancers12020495 (2020).","DOI":"10.3390\/cancers12020495"},{"key":"73581_CR33","doi-asserted-by":"publisher","unstructured":"Brown, G. Targeting the retinoic acid pathway to Eradicate Cancer Stem cells. Int. J. Mol. Sci.24. https:\/\/doi.org\/10.3390\/ijms24032373 (2023).","DOI":"10.3390\/ijms24032373"},{"key":"73581_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s12885-020-06818-0","volume":"20","author":"W Yao","year":"2020","unstructured":"Yao, W. et al. All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells. BMC Cancer. 20, 315. https:\/\/doi.org\/10.1186\/s12885-020-06818-0 (2020).","journal-title":"BMC Cancer"},{"key":"73581_CR35","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1093\/carcin\/bgv018","volume":"36","author":"MJ Young","year":"2015","unstructured":"Young, M. J. et al. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells. Carcinogenesis. 36, 498\u2013507. https:\/\/doi.org\/10.1093\/carcin\/bgv018 (2015).","journal-title":"Carcinogenesis"},{"key":"73581_CR36","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature. 501, 328\u2013337. https:\/\/doi.org\/10.1038\/nature12624 (2013).","journal-title":"Nature"},{"key":"73581_CR37","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.stem.2020.04.012","volume":"26","author":"C Morral","year":"2020","unstructured":"Morral, C. et al. Zonation of ribosomal DNA transcription defines a stem cell hierarchy in Colorectal Cancer. Cell. Stem Cell. 26, 845\u2013861. e812 (2020).","journal-title":"Cell. Stem Cell."},{"key":"73581_CR38","doi-asserted-by":"publisher","unstructured":"Cao, W. et al. LGR5 marks targetable tumor-initiating cells in mouse liver cancer. Nat. Commun. 11, (1961). https:\/\/doi.org\/10.1038\/s41467-020-15846-0 (2020).","DOI":"10.1038\/s41467-020-15846-0"},{"key":"73581_CR39","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/hep.30704","volume":"70","author":"G Sittithumcharee","year":"2019","unstructured":"Sittithumcharee, G. et al. Dependency of Cholangiocarcinoma on cyclin D-Dependent kinase activity. Hepatology. 70, 1614\u20131630. https:\/\/doi.org\/10.1002\/hep.30704 (2019).","journal-title":"Hepatology"},{"key":"73581_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.19.00124","volume":"3","author":"T Al Baghdadi","year":"2019","unstructured":"Al Baghdadi, T. et al. Palbociclib in patients with pancreatic and biliary Cancer with CDKN2A alterations: results from the targeted Agent and profiling utilization Registry Study. JCO Precis Oncol.3, 1\u20138. https:\/\/doi.org\/10.1200\/PO.19.00124 (2019).","journal-title":"JCO Precis Oncol."},{"key":"73581_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/hep.32102","volume":"75","author":"M Arora","year":"2022","unstructured":"Arora, M. et al. Synergistic combination of cytotoxic chemotherapy and cyclin-dependent kinase 4\/6 inhibitors in biliary tract cancers. Hepatology. 75, 43\u201358. https:\/\/doi.org\/10.1002\/hep.32102 (2022).","journal-title":"Hepatology"},{"key":"73581_CR42","doi-asserted-by":"publisher","first-page":"877194","DOI":"10.3389\/fonc.2022.877194","volume":"12","author":"O Suppramote","year":"2022","unstructured":"Suppramote, O. et al. The Acquired vulnerability caused by CDK4\/6 inhibition promotes Drug Synergism between Oxaliplatin and Palbociclib in Cholangiocarcinoma. Front. Oncol.12, 877194. https:\/\/doi.org\/10.3389\/fonc.2022.877194 (2022).","journal-title":"Front. Oncol."},{"key":"73581_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1158\/1078-0432.CCR-18-0284","volume":"25","author":"X Song","year":"2019","unstructured":"Song, X. et al. Combined CDK4\/6 and Pan-mTOR inhibition is synergistic against Intrahepatic Cholangiocarcinoma. Clin. Cancer Res.25, 403\u2013413. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-0284 (2019).","journal-title":"Clin. Cancer Res."},{"key":"73581_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ncb3474","volume":"19","author":"L Liu","year":"2017","unstructured":"Liu, L. et al. G1 cyclins link proliferation, pluripotency and differentiation of embryonic stem cells. Nat. Cell. Biol.19, 177\u2013188. https:\/\/doi.org\/10.1038\/ncb3474 (2017).","journal-title":"Nat. Cell. Biol."},{"key":"73581_CR45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-020-00242-3","volume":"5","author":"S Zhang","year":"2020","unstructured":"Zhang, S., Xiong, X. & Sun, Y. Functional characterization of SOX2 as an anticancer target. Signal. Transduct. Target. Ther.5, 135. https:\/\/doi.org\/10.1038\/s41392-020-00242-3 (2020).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"73581_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.15283\/ijsc20097","volume":"13","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q., Han, Z., Zhu, Y., Chen, J. & Li, W. The role and specific mechanism of OCT4 in Cancer Stem cells: a review. Int. J. Stem Cells. 13, 312\u2013325. https:\/\/doi.org\/10.15283\/ijsc20097 (2020).","journal-title":"Int. J. Stem Cells"},{"key":"73581_CR47","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/protein\/12.12.1035","volume":"12","author":"P Corish","year":"1999","unstructured":"Corish, P. & Tyler-Smith, C. Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng.12, 1035\u20131040. https:\/\/doi.org\/10.1093\/protein\/12.12.1035 (1999).","journal-title":"Protein Eng."},{"key":"73581_CR48","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s12015-023-10557-7","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang, X., Golino, J. L., Hawk, N. V. & Xie, C. Reciprocal Interaction of Cancer Stem cells of Cholangiocarcinoma with Macrophage. Stem Cell. Rev. Rep.19, 2013\u20132023. https:\/\/doi.org\/10.1007\/s12015-023-10557-7 (2023).","journal-title":"Stem Cell. Rev. Rep."},{"key":"73581_CR49","doi-asserted-by":"publisher","unstructured":"Bian, J. et al. Characterization of immunogenicity of malignant cells with stemness in Intrahepatic Cholangiocarcinoma by single-cell RNA sequencing. Stem Cells Int.2022 (3558200). https:\/\/doi.org\/10.1155\/2022\/3558200 (2022).","DOI":"10.1155\/2022\/3558200"},{"key":"73581_CR50","doi-asserted-by":"publisher","first-page":"668851","DOI":"10.3389\/fcell.2021.668851","volume":"9","author":"A Mohan","year":"2021","unstructured":"Mohan, A., Raj Rajan, R., Mohan, G., Kollenchery Puthenveettil, P. & Maliekal, T. T. Markers and reporters to reveal the Hierarchy in Heterogeneous Cancer Stem cells. Front. Cell. Dev. Biol.9, 668851. https:\/\/doi.org\/10.3389\/fcell.2021.668851 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"73581_CR51","doi-asserted-by":"publisher","unstructured":"Xiong, L. et al. Oct4 differentially regulates chromatin opening and enhancer transcription in pluripotent stem cells. Elife. 11. https:\/\/doi.org\/10.7554\/eLife.71533 (2022).","DOI":"10.7554\/eLife.71533"},{"key":"73581_CR52","doi-asserted-by":"publisher","unstructured":"Hagey, D. W., Bergsland, M. & Muhr, J. SOX2 transcription factor binding and function. Development. 149. https:\/\/doi.org\/10.1242\/dev.200547 (2022).","DOI":"10.1242\/dev.200547"},{"key":"73581_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ydbio.2011.01.015","volume":"352","author":"SR Hutton","year":"2011","unstructured":"Hutton, S. R. & Pevny, L. H. SOX2 expression levels distinguish between neural progenitor populations of the developing dorsal telencephalon. Dev. Biol.352, 40\u201347. https:\/\/doi.org\/10.1016\/j.ydbio.2011.01.015 (2011).","journal-title":"Dev. Biol."},{"key":"73581_CR54","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3748\/wjg.v30.i9.1018","volume":"30","author":"FS Dar","year":"2024","unstructured":"Dar, F. S. et al. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World J. Gastroenterol.30, 1018\u20131042. https:\/\/doi.org\/10.3748\/wjg.v30.i9.1018 (2024).","journal-title":"World J. Gastroenterol."},{"key":"73581_CR55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/hep.31571","volume":"73","author":"L Nevi","year":"2021","unstructured":"Nevi, L. et al. DCLK1, a putative stem cell marker in human cholangiocarcinoma. Hepatology. 73, 144\u2013159. https:\/\/doi.org\/10.1002\/hep.31571 (2021).","journal-title":"Hepatology"},{"key":"73581_CR56","doi-asserted-by":"publisher","first-page":"e11031","DOI":"10.15252\/emmm.201911031","volume":"11","author":"TS Purba","year":"2019","unstructured":"Purba, T. S. et al. CDK4\/6 inhibition mitigates stem cell damage in a novel model for taxane-induced alopecia. EMBO Mol. Med.11, e11031. https:\/\/doi.org\/10.15252\/emmm.201911031 (2019).","journal-title":"EMBO Mol. Med."},{"key":"73581_CR57","doi-asserted-by":"publisher","unstructured":"He, S. et al. Transient CDK4\/6 inhibition protects hematopoietic stem cells from chemotherapy-induced exhaustion. Sci. Transl Med. 9. https:\/\/doi.org\/10.1126\/scitranslmed.aal3986 (2017).","DOI":"10.1126\/scitranslmed.aal3986"},{"key":"73581_CR58","doi-asserted-by":"publisher","unstructured":"Tsao, A. N., Chuang, Y. S., Lin, Y. C., Su, Y. & Chao, T. C. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and hedgehog signaling pathway. Oncol. Rep.47. https:\/\/doi.org\/10.3892\/or.2022.8316 (2022).","DOI":"10.3892\/or.2022.8316"},{"key":"73581_CR59","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1158\/0008-5472.CAN-17-2325","volume":"78","author":"SJ Oh","year":"2018","unstructured":"Oh, S. J. et al. Targeting cyclin D-CDK4\/6 sensitizes Immune-Refractory Cancer by blocking the SCP3-NANOG Axis. Cancer Res.78, 2638\u20132653. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2325 (2018).","journal-title":"Cancer Res."},{"key":"73581_CR60","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s12282-019-01035-5","volume":"27","author":"E Kishino","year":"2020","unstructured":"Kishino, E. et al. Anti-cell growth and anti-cancer stem cell activity of the CDK4\/6 inhibitor palbociclib in breast cancer cells. Breast Cancer. 27, 415\u2013425. https:\/\/doi.org\/10.1007\/s12282-019-01035-5 (2020).","journal-title":"Breast Cancer"},{"key":"73581_CR61","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1158\/1078-0432.CCR-18-1029","volume":"25","author":"F Li","year":"2019","unstructured":"Li, F. et al. YAP1-Mediated CDK6 activation confers Radiation Resistance in Esophageal Cancer - Rationale for the combination of YAP1 and CDK4\/6 inhibitors in Esophageal Cancer. Clin. Cancer Res.25, 2264\u20132277. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1029 (2019).","journal-title":"Clin. Cancer Res."},{"key":"73581_CR62","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/bjh.18735","volume":"201","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Abemaciclib drives the therapeutic differentiation of acute myeloid leukaemia stem cells. Br. J. Haematol.201, 940\u2013953. https:\/\/doi.org\/10.1111\/bjh.18735 (2023).","journal-title":"Br. J. Haematol."},{"key":"73581_CR63","doi-asserted-by":"publisher","first-page":"1021632","DOI":"10.3389\/fonc.2022.1021632","volume":"12","author":"S Prasopporn","year":"2022","unstructured":"Prasopporn, S. et al. Combining the SMAC mimetic LCL161 with gemcitabine plus cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma. Front. Oncol.12, 1021632. https:\/\/doi.org\/10.3389\/fonc.2022.1021632 (2022).","journal-title":"Front. Oncol."},{"key":"73581_CR64","doi-asserted-by":"publisher","first-page":"105182","DOI":"10.1016\/j.isci.2022.105182","volume":"25","author":"S Jamnongsong","year":"2022","unstructured":"Jamnongsong, S. et al. Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma. iScience. 25, 105182. https:\/\/doi.org\/10.1016\/j.isci.2022.105182 (2022).","journal-title":"iScience"},{"key":"73581_CR65","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13287-020-01997-w","volume":"11","author":"R Netsrithong","year":"2020","unstructured":"Netsrithong, R. et al. Multilineage differentiation potential of hematoendothelial progenitors derived from human induced pluripotent stem cells. Stem Cell. Res. Ther.11, 481. https:\/\/doi.org\/10.1186\/s13287-020-01997-w (2020).","journal-title":"Stem Cell. Res. Ther."},{"key":"73581_CR66","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1186\/s12885-017-3689-3","volume":"17","author":"NA Clark","year":"2017","unstructured":"Clark, N. A. et al. GRcalculator: an online tool for calculating and mining dose-response data. BMC Cancer. 17, 698. https:\/\/doi.org\/10.1186\/s12885-017-3689-3 (2017).","journal-title":"BMC Cancer"},{"key":"73581_CR67","doi-asserted-by":"publisher","first-page":"51100","DOI":"10.1074\/jbc.M409080200","volume":"279","author":"S Jirawatnotai","year":"2004","unstructured":"Jirawatnotai, S. et al. Cdk4 is indispensable for postnatal proliferation of the anterior pituitary. J. Biol. Chem.279, 51100\u201351106. https:\/\/doi.org\/10.1074\/jbc.M409080200 (2004).","journal-title":"J. Biol. Chem."},{"key":"73581_CR68","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Cancer Genome Atlas Research","year":"2013","unstructured":"Cancer Genome Atlas Research. The Cancer Genome Atlas Pan-cancer analysis project. Nat. Genet.45, 1113\u20131120. https:\/\/doi.org\/10.1038\/ng.2764 (2013).","journal-title":"Nat. Genet."},{"key":"73581_CR69","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1038\/s41598-022-06841-0","volume":"12","author":"B Dwivedi","year":"2022","unstructured":"Dwivedi, B., Mumme, H., Satpathy, S., Bhasin, S. S. & Bhasin, M. Survival genie, a web platform for survival analysis across pediatric and adult cancers. Sci. Rep.12, 3069. https:\/\/doi.org\/10.1038\/s41598-022-06841-0 (2022).","journal-title":"Sci. Rep."},{"key":"73581_CR70","unstructured":"Package, A. for Survival Analysis in R (2021)."},{"key":"73581_CR71","unstructured":"survMisc Miscellaneous Functions for Survival Data (2018)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73581-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T12:04:17Z","timestamp":1727957057000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73581-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73581"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73581-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"4 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22619"}}